FDA Approves Tryngolza for Reducing Acute Pancreatitis Risk in Severe Hypertriglyceridemia
The FDA has approved Tryngolza (olezarsen) for reducing triglycerides and the risk of acute pancreatitis in adults.
Therapeutic Area
Therapeutic area intelligence for Hypertriglyceridemia with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.